A randomised, placebo-controlled trial of the effects of IV serelaxin on myocardial blood flow and vascular function in patients with stable coronary artery disease (CAD).
27 August 2017 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker

Queen Elizabeth University Hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)
16 More presentations in this session
Access the full session
The Event
ESC Congress 2017
27 August 2017
14:00 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation






